Having doubled revenues in the last five years to around $100 million (€88 million), it is no real surprise that the moment for Inve Aquaculture to be sold by its banking shareholders, Rabobank and RBS, has finally approached.
Last week, Benchmark Holdings, Mitsui and Nutreco were all cited as being among bidders for the fish health and nutrition firm, reported Bloomberg.
Benchmark Holdings confirmed its interest in the company when its shares were suspended on the Alternative Investment Market (AIM) in London.
Stelios
